Consensus Report on Destination Therapy in Japan ― From the DT Committee of the Council for Clinical Use of Ventricular Assist Device Related Academic Societies ―
-
- Kinugawa Koichiro
- Second Department of Internal Medicine, Faculty of Medicine, University of Toyama
-
- Sakata Yasushi
- Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine
-
- Ono Minoru
- Department of Cardiac Surgery, Graduate School of Medicine, The University of Tokyo
-
- Nunoda Shinichi
- Department of Therapeutic Strategy for Severe Heart Failure, Graduate School of Medicine, Tokyo Women’s Medical University
-
- Toda Koichi
- Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine
-
- Fukushima Norihide
- Department of Transplant Medicine, National Cerebral and Cardiovascular Center
-
- Shiose Akira
- Department of Cardiovascular Surgery, Faculty of Medical Sciences, Kyushu University
-
- Oishi Shogo
- Department of Cardiology, Himeji Brain and Heart Center
-
- Yumino Dai
- Yumino Heart Clinic
-
- Imamura Teruhiko
- Second Department of Internal Medicine, Faculty of Medicine, University of Toyama
-
- Endo Miyoko
- Department of Nursing, The University of Tokyo Hospital
-
- Hori Yumiko
- Department of Transplant Medicine, National Cerebral and Cardiovascular Center
-
- Kashiwa Koichi
- Department of Medical Engineering, The University of Tokyo Hospital
-
- Aita Kaoruko
- Graduate School of Humanities and Sociology, The University of Tokyo
-
- Kojin Hiroyuki
- Department of Quality and Patient Safety, Graduate Faculty of Interdisciplinary Research, Faculty of Medicine, University of Yamanashi
-
- Tejima Yutaka
- Graduate School of Law, Kobe University
-
- Sawa Yoshiki
- Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine
この論文をさがす
抄録
<p>Destination therapy (DT) is the indication to implant a left ventricular assist device (LVAD) in a patient with stage D heart failure who is not a candidate for heart transplantation. The implantable LVAD has been utilized in Japan since 2011 under the indication of bridge to transplant (BTT). After almost 10 year lag, DT has finally been approved and reimbursed in May 2021 in Japan. To initiate the DT program in Japan, revision of the LVAD indication from BTT is necessary. Also, in-depth discussion of caregiver issues as well as end-of-life care is indispensable. For that purpose, we assembled a DT committee of multidisciplinary members in August 2020, and started monthly discussions via web-based communication during the COVID-19 pandemic. This is a summary of the consensus reached after 6 months’ discussion, and we have included as many relevant topics as possible. Clinical application of DT has just started, and we are willing to revise this consensus to meet the forthcoming issues raised during real-world clinical experience.</p>
収録刊行物
-
- Circulation Journal
-
Circulation Journal 85 (10), 1906-1917, 2021-09-24
一般社団法人 日本循環器学会
- Tweet
キーワード
詳細情報
-
- CRID
- 1390570961925739648
-
- NII論文ID
- 130008091403
-
- NII書誌ID
- AA11591968
-
- ISSN
- 13474820
- 13469843
-
- NDL書誌ID
- 031698776
-
- PubMed
- 34433758
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可